Search Results
Hans-Christian Kolberg, MD: The Importance of Reporting Data on Biosimilar Trastuzumab
Dr. Kolberg on the Safety Profile of Trastuzumab Biosimilars in Breast Cancer
ABP 980, a trastuzumab biosimilar in combination with pertuzumab
The importance of central pathology pCR review in an international multicenter neoadjuvant study...
Dr. Kolberg Discusses the LILAC Study of ABP 980
Dr. Pegram on the Development of Trastuzumab Biosimilars
De-escalation of axillary surgery
Dr. Kolberg Discusses Next Steps with ABP 980
The case for biosimilars
Trial of proposed trastuzumab biosimilar, MYL-1401O vs herceptin
Dr. med. Hans-Christian Kolberg:
Genes May Predict Trastuzumab Outcomes in Breast Cancer
